Hinge Health HNGE
$105.78 −$2.32 (-2.15%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $106.00 +0.21%
Open$107.05
Prev close$108.10
Day range$103.12 – $109.18
Volume1.65M
Market cap$8.60B
P/E (TTM)51.7
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$234.97M+52.4% YoY
Operating profit$50.33M+925.9% YoY
Net profit$57.40M+3,212.7% YoY
Diluted EPS$0.66+3,400.0% YoY
Free cash flow$112.66M+38.6% YoY
Operating cash flow$114.60M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin85.7%
Operating margin18.7%
Net margin20.8%
Return on equity65.5%
Return on assets20.2%
Return on invested capital60.4%
Current ratio1.04
Liabilities / assets65.7%
Cash & investments$294.66M
Total debt$29.16M
Net cash (debt)$265.50M
Free cash flow / sales39.4%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $234.97M | $212.82M | $182.31M | $587.86M | $170.73M |
| Total Operating Revenue | $234.97M | $212.82M | $182.31M | $587.86M | $170.73M |
| Cost of Revenue | $30.64M | $28.87M | $28.07M | $119.64M | $26.70M |
| Gross Profit | $204.33M | $183.95M | $154.23M | $468.22M | $144.03M |
| Operating Expense | $154.01M | $143.51M | $122.16M | $1.01B | $116.77M |
| Selling and Admin Expenses | $116.53M | $109.45M | $91.83M | $646.46M | $84.02M |
| -Selling & Marketing Expense | $85.24M | $81.41M | $68.80M | $316.95M | $59.49M |
| -General & Admin Expense | $31.29M | $28.04M | $23.02M | $329.51M | $24.53M |
| Research & Development | $37.47M | $34.06M | $30.34M | $368.14M | $32.76M |
| Operating Profit | $50.33M | $40.44M | $32.07M | -$546.37M | $27.26M |
| Other Income (Expense) | $3.39M | $3.99M | $3.87M | $19.11M | $4.96M |
| Other Non-Operating Income (Expenses) | $3.39M | $3.99M | $3.87M | $19.11M | $4.96M |
| Pretax Profit | $53.72M | $44.43M | $35.94M | -$527.26M | $32.22M |
| Tax | -$3.68M | $740,000.00 | $814,000.00 | $998,000.00 | $122,000.00 |
| Net Profit | $57.40M | $43.69M | $35.13M | -$528.26M | $32.10M |
| Profit from Continuing Operations | $57.40M | $43.69M | $35.13M | -$528.26M | $32.10M |
| Net Income to Parent Company | $57.40M | $43.69M | $35.13M | -$528.26M | $32.10M |
| Other Preferred Stock Dividends | $0.00 | $588,000.00 | $1.12M | -$104.17M | $0.00 |
| Net Income to Common Stockholders | $57.40M | $43.10M | $34.01M | -$424.09M | $32.10M |
| Basic EPS | $0.71 | $0.55 | $0.43 | -$7.77 | $0.39 |
| Diluted EPS | $0.66 | $0.52 | $0.41 | -$7.77 | $0.37 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $874.08M | $827.40M | $728.77M | $744.76M | $744.76M |
| Total Current Assets | $567.86M | $643.35M | $540.05M | $533.90M | $533.90M |
| Cash and Cash Equivalents & Short-Term Investments | $294.66M | $389.39M | $315.87M | $363.86M | $363.86M |
| -Cash and Cash Equivalents | $211.55M | $286.22M | $186.67M | $208.00M | $208.00M |
| -Short Term Investments | $83.10M | $103.17M | $129.20M | $155.87M | $155.87M |
| Receivables | $148.53M | $125.43M | $114.92M | $66.06M | $66.06M |
| -Accounts Receivable | $94.50M | $91.79M | $69.60M | $51.04M | $51.04M |
| -Other Receivables | $61.68M | $40.35M | $51.28M | $21.12M | $21.12M |
| -Receivables Adjustments Allowances | -$7.65M | -$6.71M | -$5.96M | -$6.09M | -$6.09M |
| Prepaid Assets | $25.00M | $35.38M | $31.34M | $30.93M | $30.93M |
| Inventory | $19.19M | $16.77M | $14.17M | $15.64M | $15.64M |
| Current Deferred Assets | $74.30M | $68.54M | $56.36M | $50.94M | $50.94M |
| Other Current Assets | $6.20M | $7.84M | $7.40M | $6.47M | $6.47M |
| Total Non-Current Assets | $306.22M | $184.05M | $188.72M | $210.86M | $210.86M |
| Net PPE | $47.31M | $17.77M | $17.31M | $17.35M | $17.35M |
| -Gross PPE | $68.31M | $37.77M | $37.68M | $37.13M | $37.13M |
| -Accumulated Depreciation | -$21.00M | -$20.00M | -$20.37M | -$19.78M | -$19.78M |
| Investments and Advances | $59.54M | $84.74M | $89.77M | $113.17M | $113.17M |
| -Available for Sale Securities | $59.54M | $84.74M | $89.77M | $113.17M | $113.17M |
| Goodwill and Other Intangible Assets | $181.36M | $66.16M | $66.38M | $66.61M | $66.61M |
| -Goodwill | $113.03M | $64.10M | $64.10M | $64.10M | $64.10M |
| -Other Intangible Assets | $68.33M | $2.06M | $2.29M | $2.51M | $2.51M |
| Other Non-Current Assets | $18.01M | $15.37M | $15.26M | $13.73M | $13.73M |
| Total Liabilities | $574.66M | $483.07M | $417.21M | $366.23M | $366.23M |
| Total Current Liabilities | $544.71M | $481.44M | $414.48M | $362.41M | $362.41M |
| Payables | $9.28M | $9.08M | $8.82M | $6.17M | $6.17M |
| -Total Tax Payable | $9.28M | $9.08M | $8.82M | $6.17M | $6.17M |
| Current Accrued Expenses | $59.27M | $42.46M | $47.40M | $39.70M | $39.70M |
| Short-Term Debt and Capital Lease Obligation | $4.72M | $4.25M | $4.23M | $4.22M | $4.22M |
| -Current Capital Lease Obligation | $4.72M | $4.25M | $4.23M | $4.22M | $4.22M |
| Current Deferred Liabilities | $459.17M | $416.47M | $340.77M | $300.86M | $300.86M |
| Total Non-Current Liabilities | $29.95M | $1.63M | $2.74M | $3.82M | $3.82M |
| Long Term Debt and Capital Lease Obligation | $29.16M | $1.63M | $2.74M | $3.82M | $3.82M |
| -Long Term Capital Lease Obligation | $29.16M | $1.63M | $2.74M | $3.82M | $3.82M |
| Non-Current Deferred Liabilities | $795,000.00 | – | – | – | – |
| Total Equity | $299.42M | $344.33M | $311.56M | $378.54M | $378.54M |
| Stockholders' Equity | $299.42M | $344.33M | $311.56M | $378.54M | $378.54M |
| Capital Stock | $0.00 | $0.00 | $199.87M | $199.87M | $199.87M |
| -Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Preferred Stock | $0.00 | $0.00 | $199.87M | $199.87M | $199.87M |
| Additional Paid-In Capital | $1.22B | $1.32B | $1.13B | $1.23B | $1.23B |
| Retained Earnings | -$914.78M | -$972.18M | -$1.02B | -$1.05B | -$1.05B |
| Gains/Losses Not Affecting Retained Earnings | -$921,000.00 | -$364,000.00 | -$348,000.00 | -$20,000.00 | -$20,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $114.60M | $101.41M | $43.08M | $171.44M | $63.89M |
| Net cash flow from continuing operations | $114.60M | $101.41M | $43.08M | $171.44M | $63.89M |
| Net Income from Continuing Operations | $57.40M | $43.69M | $35.13M | -$528.26M | $32.10M |
| Depreciation & Depletion & Amortization | $2.22M | $1.06M | $1.17M | $5.13M | $1.22M |
| Deferred Tax | -$3.31M | $13,000.00 | $0.00 | $53,000.00 | -$93,000.00 |
| Other Non-Cash Items | $22.87M | $20.01M | $17.11M | $50.10M | $15.11M |
| Change in Working Capital | $14.42M | $15.36M | -$22.16M | -$2.01M | -$1.32M |
| -Change in Receivables | -$18.42M | -$12.12M | -$48.86M | -$26.63M | $20.98M |
| -Change in Inventory | -$2.12M | -$2.60M | $1.47M | -$4.76M | -$1.82M |
| -Change in Prepaid Assets | $9.41M | -$7.73M | -$3.59M | -$15.78M | -$7.77M |
| -Change in Payables and Accrued Expense | $10.00M | -$8.65M | $11.25M | $29.41M | $4.42M |
| -Change in Other Current Assets | $492,000.00 | $331,000.00 | -$658,000.00 | -$181,000.00 | $7.97M |
| -Change in Other Current Liabilities | -$898,000.00 | -$1.08M | -$1.07M | -$3.72M | -$995,000.00 |
| -Change In Other Working Capital | $15.96M | $47.23M | $19.31M | $19.64M | -$24.10M |
| Net cash flow from investing | -$64.18M | $28.62M | $48.08M | -$113.76M | -$37.70M |
| Net Cash Flow from Continuing Investing Activities | -$64.18M | $28.62M | $48.08M | -$113.76M | -$37.70M |
| Capital Expenditure | -$1.57M | -$1.73M | -$1.45M | -$5.36M | -$1.96M |
| Net PPE Purchase and Sale | -$376,000.00 | -$123,000.00 | -$83,000.00 | -$708,000.00 | -$408,000.00 |
| Net Business Purchase and Sale | -$106.39M | $0.00 | $0.00 | -$4.00M | $0.00 |
| Net Investment Purchase and Sale | $44.16M | $30.47M | $49.61M | -$103.70M | -$35.33M |
| Financing Cash Flow | -$122.26M | -$30.48M | -$112.85M | -$150.47M | -$79.55M |
| Net Cash Flow from Continuing Financing Activities | -$122.26M | -$30.48M | -$112.85M | -$150.47M | -$79.55M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | $0.00 | $4.93M | $0.00 |
| Net Common Stock Issuance | -$25.89M | -$26.53M | -$104.97M | $190.65M | -$65.03M |
| Proceeds from Stock Option Exercised | $202,000.00 | $7.55M | $410,000.00 | $9.53M | $8.74M |
| Net Other Financing Charges | -$96.57M | -$11.50M | -$8.29M | -$355.58M | -$23.26M |
| Ending Cash Balance | $215.84M | $287.67M | $188.11M | $209.80M | $209.80M |
| Net Change in Cash | -$71.83M | $99.55M | -$21.68M | -$92.79M | -$53.35M |
| Beginning Cash Balance | $287.67M | $188.11M | $209.80M | $302.59M | $263.14M |
| Free Cash Flow | $112.66M | $99.56M | $41.55M | $165.38M | $61.53M |
No comments yet — be the first to weigh in on HNGE.
Sign in to join the discussion.